Calla Lily Clinical Care

Drug Delivery · London, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of women-specific drug-delivery systems designed to improve patient outcomes. Calla Lily Clinical Care is based in London, United Kingdom and was founded in 2021. Its last reported valuation was $14.4 million in Jan 2025. It has raised $6.9 million across 1 recorded round; the latest was an accelerator round in Mar 2025.

Last reported valuation
$14.4M
Oct 2026
Priced at
—
Total raised
$6.9M
Last round
Accelerator/Incubator
Mar 2025

Who backs Calla Lily Clinical Care?

5 investors
InvestorType
Innovate UKOther
Springboard EnterprisesOther
Conduit Connect—
HH Global Partners—
Science Center—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Calla Lily Clinical Care investors

5 investors are on record for Calla Lily Clinical Care, including Innovate UK, Springboard Enterprises, Conduit Connect and HH Global Partners.

Free account
More of Calla Lily Clinical Care with a free account
  • ·Watch Calla Lily Clinical Care: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Calla Lily Clinical Care in drug delivery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View